Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Ren-huan Yu"'
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
ObjectivesGalactose-deficient IgA1 (Gd-IgA1) is a critical effector molecule in the pathogenesis of IgA nephropathy (IgAN), a leading renal disease without noninvasive assessment options. This updated systematic review aimed to determine the diagnost
Externí odkaz:
https://doaj.org/article/0093cbdae42649828b6f3560f27a5dd1
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Jianpi Qushi Heluo Formula (JQHF) is an empirical traditional Chinese medicine prescription for treating Membranous Nephropathy (MN) clinically in China. The therapeutic effect of JQHF has been reported in our previous studies. However, the
Externí odkaz:
https://doaj.org/article/9d54a12505ce48c9a1248000f2230f36
Autor:
Rui Lang, Xin-Hui Wang, Ai-Feng Li, Ying Liang, Bao-Chen Zhu, Bin Shi, Yong-Qiu Zheng, Ren-Huan Yu
Publikováno v:
Chronic Diseases and Translational Medicine, Vol 6, Iss 2, Pp 124-133 (2020)
Background: The incidence of idiopathic membranous nephropathy (IMN) has recently increased remarkably. Immune dysfunction caused by disordered intestinal flora might be an important factor affecting IMN. The Jian Pi Qu Shi Formula (JPQSF) shows prom
Externí odkaz:
https://doaj.org/article/4ca5ec80468b4a1e82b8ad5dc338fc75
Autor:
Xin-Hui Wang, Ya-Nan Yang, Ying Liang, Rui Lang, Qin Zeng, Lei Yan, Ren-Huan Yu, Chong-Ming Wu
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 145, Iss , Pp 112475- (2022)
Background: Jianpi-Qushi-Heluo formula (JQHF) has been used to treat idiopathic membranous nephropathy (IMN) in hospitals for many years. Purpose: Elucidating the protective effect and exploring the potential mechanism of JQHF against IMN. Methods: P
Externí odkaz:
https://doaj.org/article/8913f1e8b09f4e7f9dff7382c4399366
Autor:
Ying Zheng, Guang-Yan Cai, Li-Qun He, Hong-Li Lin, Xiao-Hong Cheng, Nian-Song Wang, Gui-Hua Jian, Xu-Sheng Liu, Yu-Ning Liu, Zhao-Hui Ni, Jing-Ai Fang, Han-Lu Ding, Wang Guo, Ya-Ni He, Li-Hua Wang, Ya-Ping Wang, Hong-Tao Yang, Zhi-Ming Ye, Ren-Huan Yu, Li-Juan Zhao, Wen-Hua Zhou, Wen-Ge Li, Hui-Juan Mao, Yong-Li Zhan, Zhao Hu, Chen Yao, Ri-Bao Wei, Xiang-Mei Chen
Publikováno v:
Chinese Medical Journal, Vol 130, Iss 20, Pp 2402-2409 (2017)
Background: Chronic kidney disease (CKD) with moderate-to-severe renal dysfunction usually exhibits an irreversible course, and available treatments for delaying the progression to end-stage renal disease are limited. This study aimed to assess the e
Externí odkaz:
https://doaj.org/article/89106fbf012e45b5acf3d74a66f9950a
Publikováno v:
World Journal of Clinical Cases. 11:566-575
Publikováno v:
BioMed Research International. 2023:1-9
Background. Galactose-deficient IgA1 (Gd-IgA1) is a critical initiating factor in the pathogenesis of IgA nephropathy (IgAN), which plays an important role in the diagnosis and evaluation of this disease. Moreover, the whole pathogenesis process has
Jianpi Qushi Heluo Formula (JQHF) is an empirical traditional Chinese medicine prescription for treating membranous nephropathy (MN) clinically in China. The therapeutic effect of JQHF has been reported in our previous studies. However, the exact mec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9aa6ef11f15787ba18eceeb1f132dc15
https://doi.org/10.21203/rs.3.rs-136749/v1
https://doi.org/10.21203/rs.3.rs-136749/v1
Autor:
Zhaohui Ni, Jing-Ai Fang, Chen Yao, Han-Lu Ding, Hong-Tao Yang, Hui-Juan Mao, Gui-Hua Jian, Li-Hua Wang, Wang Guo, Ying Zheng, Zhi-Ming Ye, Xiangmei Chen, Hongli Lin, Yongli Zhan, Niansong Wang, Yu-Ning Liu, Li-qun He, Xusheng Liu, Zhao Hu, Ren-Huan Yu, Li-Juan Zhao, Ya-Ping Wang, Xiao-Hong Cheng, Guangyan Cai, Yani He, Wen-Hua Zhou, Wenge Li
Publikováno v:
Chinese Journal of Integrative Medicine. 25:168-174
To follow up the participants of the randomized clinical trial “Efficacy and Safety of Niaoduqing Particles (尿毒清颗粒) for Delaying Moderate-to-Severe Renal Dysfunction”, and assess the long-term effects of Niaoduqing Particles on delaying
Publikováno v:
Integrative Medicine in Nephrology and Andrology. 8:3
Membranoproliferative glomerulonephritis (MPGN) is usually characterized by refractory nephrotic syndrome and is associated with a poor prognosis. An older patient diagnosed with MPGN had a 20-year history of proteinuria and had clinical manifestatio